ISD Immunotech (private company)

See something wrong or missing? Let us know
Offices:Aarhus
Business model:B2B

ISD Immunotech is developing a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE)  patients.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to ISD Immunotech

Name Criteria
Denmark Draupnir Bio
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
Netherlands Leyden Labs
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
Switzerland Synendos Therapeutics
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
United Kingdom ReViral
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
United Kingdom Ori Biotech
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
Hungary Turbine
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
Sweden Aprea Therapeutics
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
Norway Zelluna Immunotherapy As
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
United Kingdom Achilles Therapeutics
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
United Kingdom Entia
43%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
Top